Search
Tractament farmacològic de la malaltia d’Alzheimer: informe del Registre de Tractament Farmacològic de la Malaltia d’Alzheimer a l’any 2018
(2019)
Alzheimer's disease (MA) is a progressive and irreversible neurodegenerative disorder usually a slow but sustained development over time. MA is the most frequent cause of dementia (69%). Its prevalence is 5.1% and increases ...
Venetoclax en monoteràpia per al tractament de la leucèmia limfocítica crònica
(2019-02-01)
Chronic lymphocytic leukemia (LLC) is the most frequent type of leukemia in adults in the western world, representing 25-50% of all leukemia. The median age at diagnosis is 72 years and only 10% of patients are <55 years. ...
Problemes cardiovasculars i patologia crònica de salut mental i addiccions: anys 2012-2017 (28/2019)
(2019-03)
The diseases of the cardiovascular system are the second leading cause of death in Catalonia, with 27% of the total deaths (29% in women and 25% in men). This set of diseases has a great impact on the quality of life of ...
Tractament de l'artritis reumatoide activa de moderada a greu quan la resposta als FAMM ha estat inadequada: informe d'avaluació de resultats 2019
(2019)
Rheumatoid arthritis (RA) is a chronic disease Invalid autoimmune due to unknown cause, which It consists of a destructive inflammation of the joints, It can also affect other parts of the body. There are no curative ...
Axicabtagen ciloleucel i tisagenlecleucel per al tractament del limfoma B de cèl·lules grans
(2019-03-21)
Axicabtagen ciloleucel and tisagenlecleucel are two gene therapies that contain
T-lymphocytes of the patient previously manipulated so they express themselves
membrane, chimeric antigenic receptor or CAR. This receiver ...